Deciduous Therapeutics

San Francisco, US · 2 known investors

Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders. The company serves patients with conditions driven by cellular aging and senescence.

BiotechDigital HealthLongevity